Imran is a founding partner at Action Potential Venture Capital, a fund focused on investing in whitespace non-drug therapies such as bioelectronic medicines and their enabling technologies. The fund is backed by the pharmaceutical company, GlaxoSmithKline (GSK). Imran is based in Cambridge, MA.
Imran represents Action Potential as a board member at NeuSpera Medical, SetPoint Medical, Axon Therapies and Alpheus Medical. Prior to his role at Action Potential, Imran headed up GSK’s Investment Management group and was responsible for accessing technology and innovation external to GSK by making and managing investments in life science venture capital funds and companies.
Imran received his bachelor’s degree in finance from Concordia University in his native Canada and has trained as a Chartered Accountant. He serves on the Advisory Board of the Harvard HealthTech Fellowship and as a Mentor for the Neuro stream at the Creative Destruction Labs at the University of Toronto. Imran is a member of the Board of Trustees of the Hartford International University for Peace and Religion and is a member of the Board of Ambassadors of the Brooke Charter School in Boston.